The 36-month beta value for MRUS is also noteworthy at 1.12. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 4 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MRUS is 58.58M, and at present, short sellers hold a 14.09% of that float. The average trading volume of MRUS on January 17, 2025 was 576.74K shares.
MRUS) stock’s latest price update
The stock of Merus N.V (NASDAQ: MRUS) has increased by 0.48 when compared to last closing price of 39.65.Despite this, the company has seen a loss of -9.14% in its stock price over the last five trading days. globenewswire.com reported 2025-01-12 that NEW HAVEN, Conn. and UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 12, 2025 (GLOBE NEWSWIRE) — Biohaven Ltd. (NYSE: BHVN) and Merus N.V. (Nasdaq:MRUS), today announced a research collaboration and license agreement to co-develop three novel bispecific antibody drug conjugates (ADCs), leveraging Merus’ leading Biclonics® technology platform, and Biohaven’s next-generation ADC conjugation and payload platform technologies.
MRUS’s Market Performance
Merus N.V (MRUS) has experienced a -9.14% fall in stock performance for the past week, with a -6.92% drop in the past month, and a -23.82% drop in the past quarter. The volatility ratio for the week is 8.18%, and the volatility levels for the past 30 days are at 4.76% for MRUS. The simple moving average for the past 20 days is -4.67% for MRUS’s stock, with a -18.95% simple moving average for the past 200 days.
Analysts’ Opinion of MRUS
Many brokerage firms have already submitted their reports for MRUS stocks, with Goldman repeating the rating for MRUS by listing it as a “Buy.” The predicted price for MRUS in the upcoming period, according to Goldman is $73 based on the research report published on November 21, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see MRUS reach a price target of $72. The rating they have provided for MRUS stocks is “Buy” according to the report published on October 24th, 2024.
Truist gave a rating of “Buy” to MRUS, setting the target price at $69 in the report published on March 28th of the previous year.
MRUS Trading at -10.82% from the 50-Day Moving Average
After a stumble in the market that brought MRUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.34% of loss for the given period.
Volatility was left at 4.76%, however, over the last 30 days, the volatility rate increased by 8.18%, as shares sank -11.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.60% lower at present.
During the last 5 trading sessions, MRUS fell by -9.58%, which changed the moving average for the period of 200-days by -12.28% in comparison to the 20-day moving average, which settled at $41.78. In addition, Merus N.V saw -5.26% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MRUS starting from Shuman Harry, who sale 2,500 shares at the price of $54.00 back on Aug 21 ’24. After this action, Shuman Harry now owns 7,002 shares of Merus N.V, valued at $135,000 using the latest closing price.
Shuman Harry, the VP Controller, PAO of Merus N.V, sale 2,500 shares at $54.00 during a trade that took place back on Aug 20 ’24, which means that Shuman Harry is holding 7,002 shares at $135,000 based on the most recent closing price.
Stock Fundamentals for MRUS
Current profitability levels for the company are sitting at:
- -6.43 for the present operating margin
- -0.04 for the gross margin
The net margin for Merus N.V stands at -6.81. The total capital return value is set at -0.3. Equity return is now at value -44.60, with -36.59 for asset returns.
Based on Merus N.V (MRUS), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -87.44. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -18.45.
Currently, EBITDA for the company is -154.01 million with net debt to EBITDA at 1.73. When we switch over and look at the enterprise to sales, we see a ratio of 64.07. The receivables turnover for the company is 9.25for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.32.
Conclusion
In summary, Merus N.V (MRUS) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
